Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
3.94M
-
Shares change
-
-151K
-
Total reported value, excl. options
-
$304M
-
Value change
-
-$11.1M
-
Number of buys
-
2
-
Number of sells
-
-3
-
Price
-
$77.16
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q4 2023
7 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q4 2023.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.94M shares
of 152M outstanding shares and own 2.59% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (18.2M shares), BlackRock Inc. (18.1M shares), STATE STREET CORP (6.33M shares), BAMCO INC /NY/ (5.35M shares), Select Equity Group, L.P. (4.56M shares), MORGAN STANLEY (4.09M shares), GEODE CAPITAL MANAGEMENT, LLC (3.72M shares), NEUBERGER BERMAN GROUP LLC (3.69M shares), BROWN CAPITAL MANAGEMENT LLC (3.55M shares), and DF DENT & CO INC (3.24M shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.